A world free of polio-the final steps

New England Journal of Medicine

Volumn 374, Issue 6, 2016, Pages 501-503

  Patel, Manish ^a   Orenstein, Walter ^b  

^a Task Force for Global Health   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; VIRUS ANTIGEN;

DISEASE ERADICATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; IMMUNITY; IMMUNIZATION; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; VACCINE PRODUCTION; VIRUS VIRULENCE; DISEASE OUTBREAKS; HEALTH; PATHOGENICITY; PROCEDURES; STANDARDS; TRANSMISSION; VIROLOGY;

DISEASE ERADICATION; DISEASE OUTBREAKS; GLOBAL HEALTH; HUMANS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL;

EID: 84959302406     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1514467     Document Type: Review

References (5)

1. World Health Organization. Meeting of the SAGE Polio Working Group. WHO, Geneva, 7-8 September 2015 (http://www.who.int/immunization/sage/meetings/2015/october/2-SAGE-WG-report-draft-Final-clean.pdf).
2. Thompson KM, Duintjer Tebbens RJ. Modeling the dynamics of oral poliovirus vaccine cessation. J Infect Dis 2014; 210: Suppl 1: S475-84.
3. Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Polio endgame: the global introduction of inactivated polio vaccine. Expert Rev Vaccines 2015; 14: 749-62.
4. World Health Organization. Strategic Advisory Group of Experts on Immunization (SAGE). WHO, Geneva, 20-22 October 2015 (http://www.who.int/immunization/sage/meetings/2015/october/sage-report-oct-2015.pdf).
5. Estívariz CF, Anand A, Gary HE Jr, et al. Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, noninferiority, randomised, controlled trial. Lancet Infect Dis 2015; 15: 898-904.